je.st
news
U.S. senators ask Gilead to explain cost of Sovaldi hepatitis drug
2014-07-11 18:47:55| Biotech - Topix.net
Two members of the U.S. Senate Finance Committee, including Chairman Ron Wyden, on Friday asked Gilead Sciences Inc to defend the more than $80,000 cost of its breakthrough treatment for hepatitis C, citing the expense to federal healthcare programs.
Tags: cost
drug
explain
senators
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||